Vor Biopharma Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
VOR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Cambridgepark Drive, Suite 101, Cambridge, MA

Insiders trading volume in the past year

Vor Biopharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $69.6M -$33.7M -32.6% Oct 28, 2025
Reprogrammed Interchange LLC 10%+ Owner $35.1M -$11.2M -24.2% Oct 17, 2025
Kush Parmar Director, 10%+ Owner $3.22M Jun 14, 2022
5AM Ventures VI, L.P. 10%+ Owner $3.22M Nov 16, 2021
Sandesh Mahatme Cfo $2.08M Jul 9, 2025
Robert Ang PRESIDENT AND CEO, Director $510K May 6, 2025
Nathan D. Jorgensen Chief Financial Officer $331K May 6, 2024
Eyal C. Attar Chief Medical Officer $180K -$19.6K -9.82% Feb 13, 2025
Qing Che Zuraw Chief Development Officer $141K Jul 17, 2025
Tirtha Chakraborty Chief Sci Off & Head Tech Ops $122K May 6, 2025
Amy Quinlan Vice President of Finance $43.3K Nov 6, 2024
Han Wook Choi Chief Financial Officer $33.8K May 1, 2025
Christopher Slapak Chief Medical Officer Feb 1, 2022
Fouad Namouni Director May 22, 2025
Daniella Beckman Director May 22, 2025
Joshua Resnick Director May 22, 2025
Alexander Cumbo Director Jul 16, 2025
Sarah Burgess Reed Director Sep 8, 2025
Jean-Paul Kress CEO and Chairman, Director Jun 26, 2025
Michel Detheux Director Jul 16, 2025
David Lubner Director May 22, 2025
Sven Ante Lundberg Director May 22, 2025
Matthew R. Patterson Director May 22, 2025
Erez Kalir Director May 22, 2025

Recent Insider Transactions by Companies or Individuals for Vor Biopharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.